PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).
They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy. PARP inhibitors appear to improve progression-free survival in women with recurrent platinum-sensitive ovarian cancer, as evidenced mainly by olaparib added to conventional treatment.
In our report, we only study four approved PARPi (Lynparza, Zejula, Rubraca and Talzenna). One unit is one tablet or one capsule.
According to the new market research report “Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Report 2023-2029”, published by QYResearch, the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size is projected to reach USD 14.69 billion by 2029, at a CAGR of 11.1% during the forecast period.
- Global PARP (Poly ADP-Ribose Polymerase) Inhibitor MarketSize(US$ Million), 2018-2029
Based on or includes research from QYResearch: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Report 2023-2029.
- Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Top6Players Ranking and Market Share（Based on data of 2021, Continually updated）
Based on or includes research from QYResearch: 2021 data information of Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Report 2023-2029.
The global key manufacturers of PARP (Poly ADP-Ribose Polymerase) Inhibitor include AstraZeneca, Merck & Co, etc. In 2021, the global top three players had a share approximately 85.0% in terms of revenue.
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.